Sharda Cropchem Ltd
Sharda Cropchem Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Sharda Cropchem Limited expects FY 2026 revenue growth of around 15%. Sharda Cropchem Limited expects revenue growth of around 15% for FY 2026. - EBITDA margin guidance is maintained in the range of 15% to 18%, with a possibility to touch the higher side. - Gross margins are expected to sustain at around 35%-36% for the full year, driven by stable business conditions and favorable forex movements. - PAT grew 424% YoY in Q1 FY26, supported by strong revenue and margin expansion. - The company is investing in registrations and planned CAPEX of Rs.
From Sharda Cropchem Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Sharda Cropchem Limited expects FY 2026 revenue growth of around 15%.
- In Q1 FY 2026, revenue grew 25% year-on-year to Rs. 985 crores, with overall volume growth of 13%.
- Agrochemical segment volume grew 11%, while non-agrochemical segment volume grew 59% year-on-year.
- The company maintains a robust registration pipeline with over 1,000 product registrations pending approval, supporting future growth.
- CAPEX planned at Rs. 400-450 crores for the year to support product registrations and expansion.
- European region, a major contributor, showed strong sales growth of 43% in revenues.
- Pricing improvements are slow but steady, supporting margin and revenue growth.
2 more points from Sharda Cropchem Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Sharda Cropchem Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- CAPEX for Q1 FY26 stood at Rs. 114 crores.
- Planned CAPEX for the full year FY26 is Rs. 400-Rs. 450 crores.
- The company aims to increase product registrations backed by this CAPEX.
- No significant strategic changes reported in registration pipeline strategy, continuing with the existing registrations unless products get banned.
2 more points from Sharda Cropchem Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sharda Cropchem Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- As of 30th June 2025, Sharda Cropchem has 2,981 registrations.
- Additionally, there are 1,021 applications for product registrations at the approval stage.
- There was no specific mention of the current or expected order book value or pending orders in the Q1 FY26 earnings call transcript.
2 more points from Sharda Cropchem Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Sharda Cropchem Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹319 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sharda Cropchem Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Sumitomo Chemical India Ltd (Q1 FY26)
1,056.8 crore, up 26% YoY from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Paradeep Phosphates Ltd (Q1 FY26)
Q1 volume growth was strong at 34% YoY; NPK volumes grew 48% (Pages 4, 14). Key concall takeaways from Paradeep Phosphates Ltd's Q1 FY26 earnings call — and…
- Indogulf Cropsciences Ltd (Q1 FY26)
Expansion of manufacturing capacity by 50-60% by fiscal end will support higher sales volumes and revenue. Key concall takeaways from Indogulf Cropsci's Q1…
- Meghmani Organics Ltd (Q1 FY26)
Utilization in crop protection plants is currently around 76-77%; growth will be driven by higher-value products and increased conversion into formulations…
Arthneeti Pro · Annual
Sharda Cropchem Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sharda Cropchem Ltd Q1 FY26 results?
Sharda Cropchem Limited expects FY 2026 revenue growth of around 15%. Sharda Cropchem Limited expects revenue growth of around 15% for FY 2026. - EBITDA margin guidance is maintained in the range of 15% to 18%, with a possibility to touch the higher side. - Gross margins are expected to sustain at around 35%-36% for the full year, driven by stable business conditions and favorable forex movements. - PAT grew 424% YoY in Q1 FY26, supported by strong revenue and margin expansion. - The company is investing in registrations and planned CAPEX of Rs.
What is Sharda Cropchem Ltd share price analysis?
Sharda Cropchem Ltd currently shows a neutral. The stock trades at a P/E of 11.3 with a market cap of ₹7,095 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sharda Cropchem Ltd planning capital expenditure?
CAPEX for Q1 FY26 stood at Rs.
Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.